To observe the effect of thumb-tack needles based on "Biaoben acupoint compatibility" on sequela symptoms, mental state and pulmonary ventilation function in patients with coronavirus disease 2019 (COVID-19) during recovery period.Fifty cases of COVID-19 during recovery period were randomly divided into an observation group and a control group, 25 cases in each group. The patients in the observation group were treated with thumb-tack needles at Guanyuan (CV 4), Zusanli (ST 36) and Taiyuan (LU 9). The patients in the control group were treated with sham thumb-tack needles at identical acupoints as the observation group. The treatment in the two groups was given once a day, 7-day treatment was taken as a course of treatment, and totally two courses of treatment were given. The TCM symptom score, Hamilton anxiety scale (HAMA) score, Hamilton depression scale (HAMD) score, pulmonary function (forced vital capacity [FVC], forced expiratory volume in the first second [FEV1], peak expiratory flow [PEF]), the severity of pulmonary ventilation dysfunction and pulmonary imaging changes in the two groups were compared before and after treatment.Compared before treatment, the total scores and each item scores of TCM symptom scale, HAMA scores and HAMD scores in the two groups were reduced after treatment (P<0.05). Except for the symptom scores of dry throat and dry stool, the total score and each item score of TCM symptom scale, HAMA score and HAMD score in the observation group were lower than those in the control group (P<0.05). Compared before treatment, FVC, FEV1 and PEF in the two groups were increased after treatment (P<0.05), and those in the observation group were higher than the control group (P<0.05). The severity of pulmonary ventilation dysfunction in the two groups was reduced after treatment (P<0.05), and the severity in the observation group was better than that in the control group (P<0.05). After treatment, the lung shadow area in the two groups was decreased (P<0.05), and that in the observation group was smaller than the control group (P<0.05). The improvement of imaging change in the observation group was better than that in the control group (P<0.05).The thumb-tack needles based on "Biaoben acupoint compatibility" could significantly reduce the sequela symptoms, anxiety and depression in patients with COVID-19 during recovery stage, and improve the pulmonary ventilation function.目的：观察“标本配穴”揿针对新型冠状病毒肺炎恢复期患者后遗症状、精神状态及肺通气功能的影响。方法：将50例新型冠状病毒肺炎恢复期患者随机分为观察组和对照组，各25例。观察组采用揿针治疗，穴取关元、足三里、太渊；对照组选用特制皮内针具进行假埋针处理，取穴同观察组。每天1次，7 d为一疗程，共治疗2个疗程。比较两组患者治疗前后中医症状评分、汉密尔顿焦虑量表（HAMA）评分、汉密尔顿抑郁量表（HAMD）评分、肺功能参数[用力肺活量（FVC）、第1秒用力呼气容积（FEV1）、潮气峰流量（PEF）]、肺通气功能障碍程度及肺部影像学变化。结果：治疗后，两组患者中医症状总分及各项评分、HAMA评分、HAMD评分均较治疗前降低（P<0.05）；除咽干和大便干结评分外，观察组患者中医症状总分及各项评分、HAMA评分、HAMD评分均低于对照组（P<0.05）。治疗后，两组患者FVC、FEV1、PEF均较治疗前升高（P<0.05），且观察组高于对照组（P<0.05）；两组患者肺通气功能障碍程度减轻（P<0.05），且观察组优于对照组（P<0.05）。治疗后，两组患者肺部阴影面积均缩小（P<0.05），且观察组小于对照组（P<0.05），观察组影像学变化改善优于对照组（P<0.05）。结论：“标本配穴”揿针治疗能明显减轻新型冠状病毒肺炎恢复期患者后遗症状以及焦虑抑郁精神症状，改善肺通气功能。.
To compare the clinical efficacy of thumb-tack needle and sodium hyaluronate eye drops for dry eye.A total of 60 patients with dry eye were randomly divided into a thumb-tack needle group and a western medication group, 30 cases in each group. Based on Biaoben Genjie theory, thumb-tack needle was applied at Zhiyin (BL 67), Lidui (ST 45), Fuyang (BL 59), Yanglao (SI 6), Jingming (BL 1) and Cuanzhu (BL 2) in the thumb-tack needle group, 2 times a week. In the western medication group, 0.1% sodium hyaluronate eye drops were applied, 3 times a day. Both groups were treated for 4 weeks. Before and after treatment, TCM symptom score, tear film break-up time (BUT), SchirmerⅠtest (SⅠT), corneal fluorescein sodium staining (FL) score and 36-item short form health survey (SF-36) score were observed, and the clinical efficacy was evaluated in the two groups.After treatment, the total scores and each item score of TCM symptom in the two groups were decreased compared with before treatment (P<0.05); except for score of visual fatigue and photophobia, the total score and each item score of TCM symptom in the thumb-tack needle group were lower than the western medication group (P<0.05). After treatment, the BUT, SⅠT and SF-36 scores were increased and the FL scores were decreased in the two groups (P<0.05); the BUT, SⅠT and SF-36 score were higher than the western medication group (P<0.05), and the FL score was lower than the western medication group (P<0.05) in the thumb-tack needle group. The total effective rate in the thumb-tack needle group was 93.3% (28/30), which was higher than 80.0% (24/30) in the western medication group (P<0.05).Thumb-tack needle based on Biaoben Genjie theory could effectively relieve clinical symptoms of dry eye patients, prolong tear film break-up time, increase tear secretion, improve tear film function and quality of life, and its curative effect is better than sodium hyaluronate eye drops.目的：比较揿针埋针与玻璃酸钠滴眼液治疗干眼的临床疗效。方法：将60例干眼患者随机分为揿针组和西药组，各30例。揿针组基于“标本根结”理论选取至阴、厉兑、跗阳、养老、睛明、攒竹行揿针埋针治疗，每周2次；西药组采用0.1%玻璃酸钠滴眼液治疗，每日3次，均治疗4周。分别于治疗前后观察两组患者中医症状评分、泪膜破裂时间（BUT）、泪液分泌试验（SⅠT）、角膜荧光素钠染色（FL）评分、健康调查简表（SF-36）评分，并评定两组临床疗效。结果：治疗后，两组患者各项中医症状评分及总分均较治疗前降低（P<0.05）；除视物疲劳、畏光症状评分外，揿针组患者各项中医症状评分及总分均低于西药组（P<0.05）。治疗后，两组患者BUT延长、SⅠT增加、FL评分降低、SF-36评分增加（P<0.05）；揿针组患者BUT、SⅠT、SF-36评分高于西药组（P<0.05），FL评分低于西药组（P<0.05）。揿针组总有效率为93.3%（28/30），高于西药组的80.0%（24/30，P<0.05）。结论：基于“标本根结”理论的揿针埋针治疗可有效缓解干眼患者临床症状，延长泪膜破裂时间，增加泪液分泌量，提高泪膜功能及患者生活质量，疗效优于玻璃酸钠滴眼液治疗。.
To observe the clinical efficacy of dynamic qi acupuncture for acute lumbar sprain, and to explore the differences of different needle retention time on the improvement of pain, lumbar mobility and lumbar dysfunction.A total of 160 patients with acute lumbar sprain were randomly divided into an observation group A (40 cases, 4 cases dropped off), an observation group B (40 cases, 2 cases dropped off), an observation group C (40 cases, 4 cases dropped off) and a medication group (40 cases, 6 cases dropped off). The patients in the observation group A, the observation group B and the observation group C were treated with acupuncture at "lumbago point" and Sanjian (LI 3) on the left side, and during the needles were kept for 10, 20 and 30 min respectively, the patients were required to take tolerable lumbar active activities, once a day; the patients in the medication group were treated with celecoxib capsules, 0.2 g each time, twice a day. All the patients were treated for 5 d. Before and after treatment, the scores of numerical rating scale-11 (NRS-11), lumbar range of motion (ROM) and modified Oswestry disability index (ODI) were observed, and the clinical efficacy of each group was evaluated.After treatment, the scores of NRS-11, ROM and ODI in each group were decreased compared before treatment (P<0.01). The decreased degree of NRS-11, ROM and ODI in each observation group was greater than that in the medication group (P<0.05), and the decreased degree of ROM and ODI in the observation group B and the observation group C was greater than that in the observation group A (P<0.05). The total effective rates were 94.4% (34/36) in the observation group A, 94.7% (36/38) in the observation group B and 97.2% (35/36) in the observation group C, respectively, which were higher than 79.4% (27/34) in the medication group (P<0.05).Dynamic qi acupuncture with needle retention for 10, 20 and 30 min all could effectively improve the pain, lumbar mobility and lumbar dysfunction in patients with acute lumbar sprain. If the lumbar dysfunction is severe, needle retention for 20 min or more is recommended.目的：观察动气针法治疗急性腰扭伤的临床疗效，探讨不同留针时间对疼痛、腰椎活动度及腰部功能障碍改善作用的差异。方法：将160例急性腰扭伤患者随机分为观察1组（40例，脱落4例）、观察2组（40例，脱落2例）、观察3组（40例，脱落4例）和西药组（40例，脱落6例）。观察1组、观察2组及观察3组予针刺“腰痛穴”和左侧三间，分别留针10、20、30 min，留针同时缓慢进行可耐受的腰部主动活动，每日1次；西药组予口服塞来昔布胶囊，每次0.2 g，每日2次，4组均治疗5 d。分别于治疗前后观察各组患者数字评分量表-11（NRS-11）、腰椎活动度（ROM）及改良Oswestry功能障碍指数（ODI）评分，并评定各组临床疗效。结果：治疗后，各组患者NRS-11、ROM及ODI评分均较治疗前降低（P<0.01）；各观察组NRS-11、ROM和ODI评分降低幅度大于西药组（P<0.05），观察2组、观察3组ROM、ODI评分降低幅度大于观察1组（P<0.05）。观察1组、观察2组、观察3组总有效率分别为94.4%（34/36）、94.7%（36/38）和97.2%（35/36），均高于西药组的79.4%（27/34，P<0.05）。结论：留针10、20、30 min动气针法均可有效改善急性腰扭伤患者疼痛、腰椎活动度和腰部功能障碍，若患者腰部功能障碍明显，推荐留针20 min及以上。.
To observe the clinical therapeutic effect of filiform-fire needling of "Biaoben acupoint combination" on the sequelae of patients with coronavirus disease 2019 (COVID-19) during the recovery period.A total of 33 patients with COVID-19 during the recovery period were treated with filiform-fire needling at the acupoints of Mingmen (GV 4), Shenzhu (GV 12), Gaohuang (BL 43), Zusanli (ST 36) and Shangjuxu (ST 37), etc., once every other day, 3 times a week, and 3 times was one course of treatment and totally 2 courses of treatment were required. The TCM symptom, Hamilton anxiety scale (HAMA) and Hamilton depression scale (HAMD) scores, pulmonary function indexes (forced vital capacity [FVC], forced expiratory volume in one second [FEV1], peak expiratory flow [PEF]) and chest CT imaging change were observed before and after treatment, and the therapeutic effect was evaluated.After treatment, the scores of TCM symptom, HAMA and HAMD were decreased compared with those before treatment (P<0.05), and the levels of FVC, FEV1 and PEF were increased compared with those before treatment (P<0.05), and the recovery rate of 22 patients with pulmonary ventilation dysfunction was 86.4% (19/22). After treatment, the lung shadow area was smaller than that before treatment (P<0.05). The effective rate of 25 patients with lung CT abnormalities was 84.0% (21/25). After treatment, 23 cases were cured, 5 cases were markedly effective, 4 cases were effective, 1 case was ineffective, the cured and markedly effective rate was 84.8%.The filiform-fire needling of "Biaoben acupoint combination" could significantly reduce the sequelae of cough, fatigue, chest tightness, etc. and mental symptoms such as anxiety and depression in patients with COVID-19 during the recovery period, and promote inflammatory exudation absorption of pulmonary lesion and improve lung ventilation function.目的：观察“标本配穴”毫火针治疗新型冠状病毒肺炎恢复期患者后遗症状的临床疗效。方法：选取33例新型冠状病毒肺炎恢复期患者行毫火针治疗，穴取命门、身柱、膏肓、足三里、上巨虚等，隔天治疗1次，每周3次，3次为一疗程，共治疗2个疗程。观察患者治疗前后中医症状、汉密尔顿焦虑量表（HAMA）及汉密尔顿抑郁量表（HAMD）评分，肺功能指标[用力肺活量（FVC）、第1秒用力呼气容积（FEV1）、呼气峰值流速（PEF）]、胸部CT影像学变化情况，并评定临床疗效。结果：治疗后，患者中医症状评分及HAMA、HAMD评分均较治疗前降低（P<0.05）。治疗后患者FVC、FEV1、PEF均较治疗前升高（P<0.05），22例遗留有肺通气功能障碍患者恢复率为86.4%（19/22）。治疗后患者肺部阴影面积较治疗前缩小（P<0.05），25例遗留有肺部CT异常的患者有效率为84.0%（21/25）。治疗后痊愈23例，显效5例，有效4例，无效1例，愈显率为84.8%。结论：“标本配穴”毫火针能明显减轻新型冠状病毒肺炎恢复期患者咳嗽、乏力、胸闷等后遗症状以及焦虑抑郁等精神症状，同时促进肺部病灶炎性渗出吸收，改善肺通气功能。.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)